20.5 C
New York
Wednesday, June 3, 2026

Tag: concept

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and...

Opus One Private Preview Event and Official Launch Celebration

Canadian and global investors gain early access to Opus One, a luxury residential development in IndiaMISSISSAUGA, ON, June 2, 2026 /CNW/ - Captain Advisory...

Colorado Community Records 500%+ Pollinator Growth with Targeted Planting Strategy, Offering Rare Bright Spot Amid National Bee Declines

A Colorado community recorded a 500% increase in pollinators since 2023, demonstrating how habitat-focused development can support biodiversity.

Slutty Vegan Spreads the Love with Newly Signed Franchise Deals in Washington, D.C. and Atlanta

World-Famous Plant-Based Burger Enters New Chapter of Growth With Experienced Operators Leading Expansion Efforts ATLANTA, June 2, 2026 /PRNewswire/ -- Slutty Vegan, the nationally...

Ping An Launches “Ping An Home” Service Brand

Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...

All Access hosted by Andy Garcia Explores Modern Financial Stewardship with Verus Financial Partners

LOS ANGELES, June 2, 2026 /PRNewswire/ -- The production team behind "All Access" program hosted by Andy Garcia is set to document the principles...

Ping An Launches “Ping An Home” Service Brand

Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...

Nanobiotix Joins the Euronext Tech Leaders Index

PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced its inclusion in the Euronext Tech Leaders segment and Euronext Tech Leaders Index, a Euronext flagship initiative dedicated to increasing the visibility and attractiveness of Europe’s leading and high-growth technology companies among international investors.

TMGM Returns as Presenter Sponsor for Jay Chou Malaysia Concert 2027

KUALA LUMPUR, Malaysia, June 2, 2026 /PRNewswire/ -- TMGM has announced its return as the Presenter Sponsor for the upcoming Jay Chou concert in Malaysia,...

Flex Showcases Scalable Power Solutions for Next-Generation AI Infrastructure at COMPUTEX 2026

New power shelf for NVIDIA Vera Rubin NVL72 platforms, 30 kW capacitive energy storage system and power modules advance the transition to 800 VDC...

1-800-STRIPER® Set To Paint The Town: Budget-Friendly Paved Lot Maintenance Comes To Charleston

Established pavement striping company launches fresh franchise location in Charleston, offering property owners affordable striping options for worn out parking lots, sport courts, and...

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

PAPZIMEOS approval marks a historic milestone for the RRP patient community as the first and only FDA-approved therapy for the treatment of adults with...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsConcept